Letter from Samuel Suede, MD, Section Chief of Cardiology and Medical Director of Cardiac Rehabilitation
Now more than ever, it is an exciting time to be caring for patients with heart and vascular disease. New developments in technology, rapidly expanding expertise in surgical and catheter-based treatments, and new treatment options derived from national clinical trials in which Englewood Hospital and Medical Center has participated have greatly expanded the options available for treating patients, including the critically ill and elderly.
At the Heart and Vascular Institute at Englewood Hospital, we are dedicated to patient- and family-centered care for those with heart and vascular conditions through a full range of treatment options that match those provided by the most highly regarded academic medical centers in the region. We have a proud history of service: Our team has performed more than 4,000 open-heart surgeries since we began this program in 2000, and it has one of the lowest mortality rates in the state for coronary bypass surgery. Last year alone, we performed more than 100 transcatheter aortic valve replacements (TAVRs) for treating severe aortic stenosis; and for more than two decades, we have been an international leader in patient blood management and bloodless surgery, which has been shown to significantly reduce the incidence of serious and life-threatening postoperative complications, including for open-heart surgery.
As ever, we are engaged in continuous improvement to drive forward quality and outcomes. With new energy, we are enhancing the Heart and Vascular Institute by aligning our efforts under four centers of excellence: structural heart disease, coronary artery disease, aortic disease and arrhythmia management. Together our surgeons, interventional and noninvasive cardiologists, cardiac electrophysiologists and vascular surgeons are working toward improving access, expanding treatment programs, pushing quality even higher, and aligning ourselves with efficient partners as we prepare for and participate in new payment models that demand the highest quality.
Among our resources for referring cardiologists and primary care physicians are recent innovations: an Impella program to support patients in cardiogenic shock or severe heart failure and complex coronary interventions; the TAVR program for treating severe aortic stenosis; the WATCHMAN device for left appendage closure to reduce the risk for stroke in people with atrial fibrillation; MitraClip procedures for managing inoperable mitral valve disease; transcatheter interventions for chronic total coronary artery occlusions; and thoracic endovascular aortic repair, a minimally invasive procedure to address aortic aneurysms. Many of these new procedures are alternatives to major surgery, giving critically ill or elderly patients a previously unavailable option.
Our expertise in these areas makes Englewood Hospital and Medical Center a leader in advanced cardiovascular care. Our goal is to work closely with cardiologists, and other referring physicians, throughout the region to ensure that all adults with heart and vascular disease can be treated close to home, with the highly personalized care for which Englewood Hospital is known.
Posted September 2017